Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-26 @ 2:33 AM
Study NCT ID:
NCT05355402
Status:
COMPLETED
Last Update Posted:
2024-11-27
First Post:
2022-04-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-26
First Submit QC Date:
None
Study First Post Date:
2022-05-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-02-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-11-22
Last Update Post Date:
2024-11-27
Last Update Post Date Type:
ACTUAL